Acarix Publishes Interim Report, January – March 2025
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the first quart...
Acarix AB’s Annual Report 2024
Acarix, a global leader in AI and advanced acoustic-based cardiac diagnostics, today announces that the Annual Report for 2024 is avail...
Acarix AB’s Årsredovisning 2024
Acarix, ledande inom avancerad akustikbaserad hjärtdiagnostik, meddelar idag att årsredovisning för 2024 finns tillg&au...
NOTICE OF ANNUAL GENERAL MEETING IN Acarix AB
The shareholders in Acarix AB (publ) corp. reg. no 559009-0667 (the “Company”) are hereby convened to an annual general mee...
KALLELSE TILL ÅRSSTÄMMA I Acarix AB
Aktieägarna i Acarix AB, org.nr 559009-0667 (”Bolaget”) kallas härmed till årsstämma tisdagen den 13 m...
Acarix AB (publ) Publishes Year-End Report 2024 – Sales and revenue for the CADScor System and patches are surging amid ongoing U.S. expansion efforts
Malmö — Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial res...
Acarix AB (publ) publicerar tredje kvartalet 2024
Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, redovisade idag sina finansiella resultat för det tredje ...
Acarix Publishes Third Quarter 2024 Report
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the third quarter of 202...
Acarix resolves on a directed issue to the guarantors of the warrant series 3
Acarix AB ("Acarix" or the "Company") today announces that the Board of Directors has resolved on a directed issue to the guarantors of...
Acarix announces outcome of warrant exercise of series 3
Acarix AB ("Acarix" or the "Company") today announces the outcome of the exercise of warrants of series 3 issued in connection with the...
Acarix informs of exercise price for the warrants of series TO 3
Acarix AB ("Acarix" or the "Company"), a leader in rapid AI and acoustics-based cardiac diagnostics, announces that the exercise price ...
Acarix AB (publ) publishes Interim Report, April – June 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 20...